These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 21455254

  • 1. Combination of vorinostat and adenovirus-TRAIL exhibits a synergistic antitumor effect by increasing transduction and transcription of TRAIL in lung cancer cells.
    Kim DR, Park MY, Lee CS, Shim SH, Yoon HI, Lee JH, Sung MW, Kim YS, Lee CT.
    Cancer Gene Ther; 2011 Jul; 18(7):467-77. PubMed ID: 21455254
    [Abstract] [Full Text] [Related]

  • 2. Genetic blockade of insulin-like growth factor-1 receptor via recombinant adenovirus in lung cancer can be enhanced by the histone deacetylase inhibitor, vorinostat.
    Park MY, Kim DR, Eo EY, Lim HJ, Park JS, Cho YJ, Yoon HI, Lee JH, Lee CT.
    J Gene Med; 2013 Jul; 15(3-4):115-22. PubMed ID: 23413016
    [Abstract] [Full Text] [Related]

  • 3. Combination therapy of conditionally replicating adenovirus and histone deacetylase inhibitors.
    Kim DR, Park MY, Lim HJ, Park JS, Cho YJ, Lee SW, Yoon HI, Lee JH, Kim YS, Lee CT.
    Int J Mol Med; 2012 Feb; 29(2):218-24. PubMed ID: 22075951
    [Abstract] [Full Text] [Related]

  • 4. The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer.
    Zhao L, Dong A, Gu J, Liu Z, Zhang Y, Zhang W, Wang Y, He L, Qian C, Qian Q, Liu X.
    Cancer Gene Ther; 2006 Nov; 13(11):1011-22. PubMed ID: 16799468
    [Abstract] [Full Text] [Related]

  • 5. Cisplatin enhances apoptosis induced by a tumor-selective adenovirus expressing tumor necrosis factor-related apoptosis-inducing ligand.
    Reddy RM, Tsai WS, Ziauddin MF, Zuo J, Cole GW, Maxhimer JB, Fang B, Schrump DS, Nguyen DM.
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):883-91. PubMed ID: 15573073
    [Abstract] [Full Text] [Related]

  • 6. Histone deacetylase inhibitors enhance Ad5-TRAIL killing of TRAIL-resistant prostate tumor cells through increased caspase-2 activity.
    VanOosten RL, Earel JK, Griffith TS.
    Apoptosis; 2007 Mar; 12(3):561-71. PubMed ID: 17195089
    [Abstract] [Full Text] [Related]

  • 7. Adenovirus-mediated TRAIL expression and downregulation of Bcl-2 expression suppresses non-small cell lung cancer growth in vitro and in vivo.
    Zhang H, Sui A, Wang Z, Liu S, Yao R.
    Int J Mol Med; 2012 Aug; 30(2):358-64. PubMed ID: 22614533
    [Abstract] [Full Text] [Related]

  • 8. [Killing effect of Ad.TERT-TRAIL on tumor cell lines and its mechanism].
    Tang YX, Chen Y, Gu JF, Qi R, Zou WG, Jiang LL, Liu XY.
    Ai Zheng; 2005 May; 24(5):536-42. PubMed ID: 15890093
    [Abstract] [Full Text] [Related]

  • 9. Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes.
    Lin T, Gu J, Zhang L, Huang X, Stephens LC, Curley SA, Fang B.
    Cancer Res; 2002 Jul 01; 62(13):3620-5. PubMed ID: 12097263
    [Abstract] [Full Text] [Related]

  • 10. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy.
    Zhang Y, Gu J, Zhao L, He L, Qian W, Wang J, Wang Y, Qian Q, Qian C, Wu J, Liu XY.
    Cancer Res; 2006 Apr 15; 66(8):4291-8. PubMed ID: 16618754
    [Abstract] [Full Text] [Related]

  • 11. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells.
    Sun SY, Yue P, Hong WK, Lotan R.
    Cancer Res; 2000 Dec 15; 60(24):7149-55. PubMed ID: 11156424
    [Abstract] [Full Text] [Related]

  • 12. Adenovirus-mediated IKKbetaKA expression sensitizes prostate carcinoma cells to TRAIL-induced apoptosis.
    Sanlioglu AD, Koksal IT, Karacay B, Baykara M, Luleci G, Sanlioglu S.
    Cancer Gene Ther; 2006 Jan 01; 13(1):21-31. PubMed ID: 16052230
    [Abstract] [Full Text] [Related]

  • 13. An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice.
    Pei Z, Chu L, Zou W, Zhang Z, Qiu S, Qi R, Gu J, Qian C, Liu X.
    Hepatology; 2004 May 01; 39(5):1371-81. PubMed ID: 15122766
    [Abstract] [Full Text] [Related]

  • 14. Histone deacetylase inhibitors and 15-deoxy-Delta12,14-prostaglandin J2 synergistically induce apoptosis.
    Koyama M, Izutani Y, Goda AE, Matsui TA, Horinaka M, Tomosugi M, Fujiwara J, Nakamura Y, Wakada M, Yogosawa S, Sowa Y, Sakai T.
    Clin Cancer Res; 2010 Apr 15; 16(8):2320-32. PubMed ID: 20371690
    [Abstract] [Full Text] [Related]

  • 15. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
    Singh TR, Shankar S, Chen X, Asim M, Srivastava RK.
    Cancer Res; 2003 Sep 01; 63(17):5390-400. PubMed ID: 14500373
    [Abstract] [Full Text] [Related]

  • 16. Enhanced antitumor effect of combining interferon beta with TRAIL mediated by tumor-targeting adeno-associated virus vector on A549 lung cancer xenograft.
    Wang Y, He L, He G, Kong Y, Liu X, Cai H, Liu X, Tan W.
    Sheng Wu Gong Cheng Xue Bao; 2010 Jun 01; 26(6):780-8. PubMed ID: 20815258
    [Abstract] [Full Text] [Related]

  • 17. Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells.
    Sung ES, Kim A, Park JS, Chung J, Kwon MH, Kim YS.
    Apoptosis; 2010 Oct 01; 15(10):1256-69. PubMed ID: 20582477
    [Abstract] [Full Text] [Related]

  • 18. Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions.
    Begue B, Wajant H, Bambou JC, Dubuquoy L, Siegmund D, Beaulieu JF, Canioni D, Berrebi D, Brousse N, Desreumaux P, Schmitz J, Lentze MJ, Goulet O, Cerf-Bensussan N, Ruemmele FM.
    Gastroenterology; 2006 Jun 01; 130(7):1962-74. PubMed ID: 16762619
    [Abstract] [Full Text] [Related]

  • 19. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ, Stilwell A, Dong YB, Yang HL, Wong SL, Wrightson WR, Martin RC, McMasters KM.
    Cancer Gene Ther; 2002 May 01; 9(5):453-63. PubMed ID: 11961668
    [Abstract] [Full Text] [Related]

  • 20. Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter.
    Jacob D, Davis J, Zhu H, Zhang L, Teraishi F, Wu S, Marini FC, Fang B.
    Clin Cancer Res; 2004 May 15; 10(10):3535-41. PubMed ID: 15161713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.